Clinical Trials Browser

Phase 1/2 × anlotinib × Sarcoma × Clear all

NCT04165330 2025-02-24

Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

Phase 1/2 Active not recruiting

SarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Sarcoma, Small Cell Lung Carcinoma

NCT05301764 2024-10-15

A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma

Phase 1/2 Recruiting

Sarcoma

NCT03416517 2019-02-15

Anlotinib and Irinotecan for Ewing Sarcoma

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Ewing